Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Treasury Shares (2020 - 2026)

Profound Medical has reported Treasury Shares over the past 5 years, most recently at $859335.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 837.42% year-over-year to $859335.0; the TTM value through Dec 2025 reached $859335.0, up 837.42%, while the annual FY2025 figure was $859335.0, 837.42% up from the prior year.
  • Treasury Shares for Q4 2025 was $859335.0 at Profound Medical, down from $963005.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.1 million in Q2 2025 and troughed at $91670.0 in Q4 2024.
  • A 4-year average of $637953.6 and a median of $538954.0 in 2025 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: crashed 81.42% in 2024 and later surged 837.42% in 2025.
  • Year by year, Treasury Shares stood at $443861.0 in 2022, then grew by 11.16% to $493396.0 in 2023, then crashed by 81.42% to $91670.0 in 2024, then surged by 837.42% to $859335.0 in 2025.
  • Business Quant data shows Treasury Shares for PROF at $859335.0 in Q4 2025, $963005.0 in Q3 2025, and $1.1 million in Q2 2025.